EMEA-001439-PIP01-13-M03
Key facts
| Invented name |
Exviera
|
| Active substance |
Dasabuvir (sodium monohydrate)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0289/2020
|
| PIP number |
EMEA-001439-PIP01-13-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of chronic hepatitis C
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
AbbVie Ltd
AbbVie Ltd |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|